Research · Sep 3, 2026
[BUD] AB InBev Thesis 2026: Premium Brand Mix Tests EM Volume Recovery
Anheuser-Busch InBev SA/NV (NYSE: BUD) FY2025 revenue ~$60-62B (+0-3%) with adj. EBITDA ~$20-21B reflecting continued premium + super-premium brand mix expansion (~57%+ revenue from premium portfolio) plus selected post-2023 Bud Light controversy stabilization in US plus continued EM volume recovery (Mexico + Brazil + Africa + China) plus continued post-2016 SAB Miller deleveraging toward ~2.6-2.8x net leverage under continued CEO Michel Doukeris (~5-year tenure since July 2021). Global brewing leader with selected ~26%+ aggregate global beer market share + selected ~50%+ Latin America + ~40%+ Africa market share producing ~500+ beer brands globally. Founded 2008 via merger of InBev (Belgium-Brazilian brewing giant formed 2004 via InterBrew + AmBev merger) + Anheuser-Busch (US brewing giant founded 1852 St. Louis Missouri) creating selected ~$52B aggregate transaction; selected post-October 2016 ~$103B SAB Miller acquisition (selected largest brewing industry transaction ever) creating selected ~26%+ global beer market share leader. Earlier AmBev Brazil formed 1999 via Brahma + Antarctica merger; InterBrew Belgium founded 1366 (Den Hoorn brewery → Stella Artois 1366 Leuven); selected one of selected world's oldest continuing brewing operations. Headquartered in Leuven Belgium; ~158,000+ employees globally with ~$60-62B revenue. Five reporting segments: North America ~25% revenue (~$15B — Anheuser-Busch US + Labatt Canada; Bud Light + Budweiser + Michelob Ultra + Stella Artois + Corona import + selected craft brands), Middle Americas ~25% (~$15B — Mexico Modelo + Corona + Central America + Caribbean), South America ~25% (~$15B — Brazil AmBev + Argentina + Uruguay + Bolivia + Chile + Paraguay), EMEA ~15% (~$9B — Stella Artois Belgium + Hoegaarden + Becks Germany + selected African brewing), Asia Pacific ~10% (~$6B — China Budweiser + selected APAC). Premium portfolio leadership: ~57%+ revenue from Premium + Super-Premium brands FY2025 (vs ~50% FY2019); Megabrands (Corona + Stella Artois + Budweiser + Bud Light + Michelob Ultra + Modelo Especial) representing ~70%+ of revenue with ~+5-7% premium revenue growth FY2025 vs ~0-2% mainstream; Beyond Beer (Cutwater RTD + non-alcoholic + wellness beverages) ~3-5% revenue. US Bud Light recovery + Michelob Ultra: post-April 2023 Bud Light + Dylan Mulvaney social media controversy resulted in ~25-30% US Bud Light volume decline FY2023 (~$1.4B aggregate impact); FY2024-2025 stabilization at ~70% prior volume; Michelob Ultra became #1 US beer dollar share March 2024; FY2026 catalyst: continued US portfolio stabilization + Michelob Ultra growth + Modelo Especial market share. EM volume recovery: ~50%+ EM revenue exposure; Mexico Middle Americas (~25%) + Brazil South America (~20%) + Africa (~5%) + China (~5%); FY2026 catalyst: continued EM volume recovery + ~+3-5% aggregate EM volume growth. CEO Michel Doukeris since July 2021 (succeeded Carlos Brito CEO 2005-July 2021 retired who led ABI through 2008 InBev + Anheuser-Busch merger + 2016 SAB Miller acquisition; Doukeris ex-ABI Zone President North America 2018-July 2021 + ~30-year company career). Capital return: ~$0.81-0.85 annual dividend FY2025 (~€0.82/share); ~$2-3B annual buybacks (post-2024 buyback resumption); selected post-2024 net leverage ~2.6-2.8x (down from peak ~5x post-2016); investment-grade Baa1/BBB+ credit ratings. FY2026 thesis: premium portfolio mix expansion + US Bud Light recovery + EM volume rebound + continued deleveraging + buyback acceleration. Risks: macro consumer recession compress premium volume, US Bud Light continued stagnation, commodity inflation aluminum + barley + glass, EM currency depreciation Brazil real + Mexican peso, alcohol regulatory.